Fig. 2From: Implementing the EffTox dose-finding design in the Matchpoint trialPosterior utility after 3 patients. Posterior densities of the utility of doses 3 and 4. After three patients with outcomes 3NTE, the densities largely occupy the same space and dose ambivalence is likelyBack to article page